Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: The randomized VIASTAR trial (viabahn endoprosthesis with propaten bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)

Journal of the American College of Cardiology

Volumn 62, Issue 15, 2013, Pages 1320-1327

  Lammer, Johannes ^a   Zeller, Thomas ^b   Hausegger, Klaus A ^c   Schaefer, Philipp J ^d   Gschwendtner, Manfred ^e   Mueller Huelsbeck, Stefan ^f   Rand, Thomas ^g   Funovics, Martin ^a   Wolf, Florian ^a   Rastan, Aljoscha ^b   Gschwandtner, Michael ^h   Puchner, Stefan ^a   Ristl, Robin ^h   Schoder, Maria ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c Klinikum Klagenfurt   (Austria)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e ELISABETHINEN HOSPITAL   (Austria)

^f Diakonissen Hospital   (Germany)

^g HIETZING HOSPITAL   (Austria)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

angioplasty; covered stent; peripheral arterial disease; stent; stent graft; superficial femoral artery

Indexed keywords

HEPARIN; NITINOL; POLITEF;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HEPARIN BONDED COVERED STENT; HUMAN; LONG FEMOROPOPLITEAL LESION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POPLITEAL ARTERY STENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SINGLE BLIND PROCEDURE; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY STENT; SURFACE PROPERTY; TREATMENT RESPONSE; VASCULAR PATENCY;

ABI; ANGIOPLASTY; ANKLE-BRACHIAL INDEX; BARE-METAL STENT(S); BMS; CDUS; CI; COLOR-CODED DOPPLER ULTRASOUND; CONFIDENCE INTERVAL; COVERED STENT; EPTFE; EXPANDED POLYTETRAFLUOROETHYLENE; INTENTION-TO-TREAT; ITT; PAD; PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; PTA; RANDOMIZED CONTROLLED TRIAL; RCT; SFA; STENT; STENT GRAFT; SUPERFICIAL FEMORAL ARTERY; TARGET LESION REVASCULARIZATION; TASC; TLR; TPP; TRANSATLANTIC INTER-SOCIETY CONSENSUS; TREATMENT PER-PROTOCOL; VIA; VIABAHN ENDOPROSTHESIS; WALKING IMPAIRMENT QUESTIONNAIRE; WIQ;

AGED; ALLOYS; ANKLE BRACHIAL INDEX; ANTICOAGULANTS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; HEPARIN; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STENTS; VASCULAR PATENCY;

EID: 84885009814     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.05.079     Document Type: Article

References (26)

1. M.H. Criqui, A. Fronek, E. Barrett-Connor, M.R. Klauber, S. Gabriel, and D. Goodman The prevalence of peripheral arterial disease in a defined population Circulation 71 1985 510 551
2. A.T. Hirsch, M.H. Criqui, and D. Treat-Jacobson Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
3. C. White Intermittent claudication N Engl J Med 356 2007 1241 1250
4. L. Norgren, W.R. Hiatt, and J.A. Dormandy Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl 1 2007 S1 S75
5. A.T. Hirsch, Z.J. Haskal, and N.R. Hertzer ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease Circulation 113 2006 e463 e465
6. M. Schillinger, S. Sabeti, and C. Loewe Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
7. J.R. Laird, B.T. Katzen, D. Scheinert RESILIENT Investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
8. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
9. M. Werk, S. Langner, and B. Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
10. M.D. Dake, G.M. Ansel, M.R. Jaff Zilver PTX Investigators Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2010 495 504
11. E. Stabile, V. Virga, and L. Salemme Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis J Am Coll Cardiol 60 2012 1739 1742
12. U. Beschorner, S. Sixt, and U. Schwarzwälder Recanalization of chronic occlusions of the superficial femoral artery using the Outback™ re-entry catheter: a single centre experience Cath Cardiovasc Intervent 74 2009 934 938
13. P. Kougias, A. Chen, C. Cagiannos, C.F. Bechara, T.T. Huynh, and P.H. Lin Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion Am J Surg 198 2009 645 649
14. P. Dick, H. Wallner, and S. Sabeti Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Intervent 74 2009 1090 1095
15. M. Bosiers, K. Deloose, and J. Callaert Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions J Vasc Surg 54 2011 1042 1050
16. D. Scheinert, S. Scheinert, and J. Sax Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
17. P.H. Lin, C. Chen, R.L. Bush, Q. Yao, A.B. Lumsden, and S.R. Hanson Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model J Vasc Surg 39 2004 1322 1328
18. G. Pedersen, E. Laxdal, V. Ellensen, T. Jonung, and E. Mattsson Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model J Cardiovasc Surg 51 2010 443 448
19. E.R. Mohler 3rd, H.L. Gornik, and M. Gerhard-Herman ACCF, ACR, AIUM, ASE, ASN, ICAVL, SCAI, SCCT, SIR, SVM, SVS ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/ SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery J Am Coll Cardiol 60 2012 242 276
20. M. Bosiers, G. Torsello, and H.M. Gissler Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study J Endovasc Ther 16 2009 261 269
21. K. Suzuki, O. Iida, and J. Soga Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry Circ J 75 2011 939 944
22. J.J. Siracuse, K.A. Giles, and F.B. Pomposelli Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease J Vasc Surg 55 2012 1001 1007
23. K. McQuade, D. Gable, G. Pearl, B. Theune, and S. Black Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 52 2010 584 590
24. P. Olsson, J. Sanchez, T.E. Mollnes, and J. Riesenfeld On the blood compatibility of end-point immobilized heparin J Biomater Sci Polym Ed 11 2000 1261 1273
25. P.H. Lin, R.L. Bush, Q. Yao, A.B. Lumsden, and C. Chen Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model J Surg Res 118 2004 45 52
26. J.S. Lindholt, B. Gottschalksen, and N. Johannesen The Scandinavian Propaten(®) trial: 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial Eur J Vasc Endovasc Surg 41 2011 668 673